Zarontin
NDC 0071-2418, Ethosuximide, solution, from Parke-Davis Div of Pfizer Inc.
- Product NDC
- 0071-2418
- Status
- Listed
- Labeler
- Parke-Davis Div of Pfizer Inc
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA080258
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0071-2418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETHOSUXIMIDE250 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0071-2418-19 | 00071241819 | 1 BOTTLE, PLASTIC in 1 CARTON (0071-2418-19) / 474 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7bf3e616-45e8-4469-a75d-4d824ce951ea
Use it
Look up 0071-2418 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0071-2418 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0071-2418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.